Sustainability
As a pharmaceutical and healthcare company, STADA is responsible for ensuring the group-wide safety of its products and thus also the safety of patients. That’s what SDG 17 is all about.
Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (1)
Austria (1)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
China (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
The Phillippines (1)
United Kingdom (3)
Vietnam (2)
Explore STADA
Your opportunity for success with STADA
We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment.
During our recent Global Leadership Call I felt proud to share that an impressive 94% of our employees expressed that uniqueness is not a barrier to career progression at STADA!
By Simone Berger,
♥️ My passion project for 2024: lab coat sponsorship for aspiring pharmacists ♥️
By Delia Heeger-Heß,
I can't be more proud of such an amazing team. Thanks for working with me.
By Christian Lang,
📢 Centrafarm at the NVZA Conference: The Butterfly Effect
By Rita Budding, Commercial Lead Hospital / Specialty at Centrafarm
At STADA Group, “Culture drives performance”! The results of our bi-annual Global Employee Survey are hot off the press.
Peter Goldschmidt, CEO, STADA
STADA Voices
Latest news
10/10/2024
EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar
26/07/2024
European Commission approval to expand label & patient group for IgA Nephropathy orphan medicine
24/06/2024
STADA Health Report 2024: Satisfaction with healthcare systems continues to decline
28/05/2024
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, EU and UK
21/05/2024
STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey
10/05/2024
Xbrane, STADA partner with Valorum Biologics to commercialize ranibizumab biosimilar candidate in the US
10/01/2024
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
This statistic is more than just a number to me. It demonstrates that we have created a workplace at STADA Group where everyone can show up as their best selves and feels valued. And it confirms that when we embrace the unique value of every employee, we pave the way for both personal growth and organizational success.
We continue to foster a growth culture where positivity and diversity thrive. This aligns with Sustainable Development Goal 8 (SDG 8), which promotes inclusive and sustainable economic growth, employment, and decent work for all.
It's a journey I'm grateful to be on!
#Uniqueness #GrowthMindset #OneSTADA #Diversity